about
Overactive bladder - 18 years - Part IEffectiveness of combined high-dosed trospium and solifenacin depending on severity of OAB symptoms in elderly men and women under cyclic therapy.Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)Content validity and test-retest reliability of Patient Perception of Intensity of Urgency Scale (PPIUS) for overactive bladder.Role of KIT-Positive Interstitial Cells of Cajal in the Urinary Bladder and Possible Therapeutic Target for Overactive BladderSacral nerve stimulation for urinary urge incontinence, urgency-frequency, urinary retention, and fecal incontinence: an evidence-based analysis.Mirabegron: a Beta-3 agonist for overactive bladder.Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin.Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis.Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.The Aging Overactive Bladder: A Review of Aging-Related Changes from the Brain to the Bladder.Differential Prescribing of Antimuscarinic Agents in Older Adults with Cognitive Impairment.
P2860
Q30388069-EF385550-02C3-440F-9CE7-6D6D8C395A55Q33819939-B05D7FF7-D00A-42E5-962D-9B2946EC0E43Q33835874-C8A1660A-0583-49DF-AD04-C985DC62093BQ34408830-AC155680-2FD5-47AA-9955-363DAD524138Q35116336-8EBB6CA8-2581-429E-8B75-6E4D0B2F23A5Q36056222-E6CDB0CE-A148-4732-9929-5DBDF68B2D4DQ36160960-3602CFE6-0F18-4C17-8043-9241F43E8203Q37187453-51A9D5FF-797F-4F96-AAEB-EAB12D4F48E7Q37405499-FAEAAED1-FCEC-4A5B-B96F-39F2EF6CF53AQ39020998-41175108-B981-4441-BFC9-1D923040CD42Q42953465-7D559989-415C-45E9-9249-9C135B43E268Q46817158-62F0756C-9798-441E-B013-A78589472D30Q50533611-04E16CA5-8335-4D92-8631-8DE7237C33B1
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The prevalence of overactive bladder.
@ast
The prevalence of overactive bladder.
@en
The prevalence of overactive bladder.
@nl
type
label
The prevalence of overactive bladder.
@ast
The prevalence of overactive bladder.
@en
The prevalence of overactive bladder.
@nl
prefLabel
The prevalence of overactive bladder.
@ast
The prevalence of overactive bladder.
@en
The prevalence of overactive bladder.
@nl
P2093
P1476
The prevalence of overactive bladder
@en
P2093
P304
P433
P577
2000-07-01T00:00:00Z